FDA Clears First OCT Angiography System

TMB Zeiss logo

ZEISS logo LGAngioPlex OCT Angiography from Zeiss Medical Technology is the first such technology to receive 510(k) clearance from the U.S. Food and Drug Administration. With a single additional OCT scan that takes just seconds on the Cirrus HD-OCT system, images of the retinal vasculature at a depth and clarity not previously available can be obtained.

AngioPlex OCT Angiography delivers high-resolution, depth-resolved visualization of the separate layers of the retinal and choroidal vasculature without the need for injection of a contrast dye. In addition, FastTrac enables follow-up OCT angiography images to be acquired at the same location for monitoring of treatment efficacy and disease progression. AngioPlex OCT Angiography can complement traditional FA as a safe and efficient part of routine eye care, potentially enabling earlier detection and management of micro-progressions. For more information, see the Zeiss website.